Valategrast

CAS No. 220847-86-9

Valategrast( —— )

Catalog No. M13520 CAS No. 220847-86-9

Valategrast is a potent, α4β1 (VLA-4) and α4β7 dual antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 284 Get Quote
50MG 1341 Get Quote
100MG 2196 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Valategrast
  • Note
    Research use only, not for human use.
  • Brief Description
    Valategrast is a potent, α4β1 (VLA-4) and α4β7 dual antagonist.
  • Description
    Valategrast is a potent, α4β1 (VLA-4) and α4β7 dual antagonist.Asthma Discontinued.
  • In Vitro
    Valategrast contains a common l-phenylalanine-N-aroyl motif where the carboxylic acid is responsible for binding to the metal ion in the metal-ion-dependent adhesion site (MIDAS).
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Integrin
  • Recptor
    Integrin
  • Research Area
    Inflammation/Immunology
  • Indication
    Asthma

Chemical Information

  • CAS Number
    220847-86-9
  • Formula Weight
    604.953
  • Molecular Formula
    C30H32Cl3N3O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 170 mg/mL (281.01 mM)
  • SMILES
    CCN(CC)CCOC(=O)C(CC1=CC=C(C=C1)NC(=O)C2=C(C=CC=C2Cl)Cl)NC(=O)C3=C(C=CC=C3Cl)C
  • Chemical Name
    2-(diethylamino)ethyl (2S)-2-[(2-chloro-6-methylbenzoyl)amino]-3-[4-[(2,6-dichlorobenzoyl)amino]phenyl]propanoate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Sidduri A, et al. Bioorg Med Chem Lett. 2002 Sep 2;12(17):2479-82.
molnova catalog
related products
  • Elarofiban TFA

    Elarofiban TFA (RWJ-53308 TFA) is a novel and orally active and selective GPIIb/IIIa antagonist for the study of cardiovascular disease.

  • Cyclo(RGDyK)

    Cyclo(RGDyK) is a potent and selective αVβ3 integrin inhibitor with IC50 of 20 nM.

  • RWJ 50271

    RWJ 50271 is a selective lymphocyte function-associated antigen-1/intercellular adhesion molecule-1(LFA-1/ICAM-1) interaction inhibitor( IC50 of 5.0 μM in HL60 cells).